Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Download references

Open Access Highly Accessed

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

Justin M Balko and Esther P Black*

BMC Cancer 2009, 9:145  doi:10.1186/1471-2407-9-145

Include


Format